EXELON CORP
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
10. Fair Value of Financial Assets and Liabilities
- Fair Value of Financial Assets and Liabilities (All Registrants)
Exelon measures and classifies fair value measurements in accordance with the hierarchy as defined by GAAP. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:
Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities that the Registrants have the ability to liquidate as of the reporting date.
Level 2 — inputs other than quoted prices included within Level 1 that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.
Level 3 — unobservable inputs, such as internally developed pricing models or third-party valuations for the asset or liability due to little or no market activity for the asset or liability.
Exelon’s valuation techniques used to measure the fair value of the assets and liabilities shown in the tables below are in accordance with the policies discussed in Note 17 — Fair Value of Financial Assets and Liabilities of the 2023 Form 10-K.
Fair Value of Financial Liabilities Recorded at Amortized Cost
The following tables present the carrying amounts and fair values of the Registrants’ short-term liabilities, long-term debt, and trust preferred securities (long-term debt to financing trusts or junior subordinated debentures) as of March 31, 2024 and December 31, 2023. The Registrants haveno financial liabilities measured using the NAV practical expedient.
The carrying amounts of the Registrants’ short-term liabilities as presented in their Consolidated Balance Sheets are representative of their fair value (Level 2) because of the short-term nature of these instruments.
| March 31, 2024 · December 31, 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carrying Amount · Fair Value · Carrying Amount · Fair Value | ||||||||||
| Level 1 · Level 2 · Level 3 · Total · Level 1 · Level 2 · Level 3 · Total | ||||||||||
| Long-Term Debt, including amounts due within one year(a) | ||||||||||
| Exelon | $42,774 | $— | $34,426 | $3,613 | $38,039 | $41,095 | $— | $33,804 | $3,442 | $37,246 |
| ComEd | 11,487 | — | 9,910 | — | 9,910 | 11,486 | — | 10,210 | — | 10,210 |
| PECO | 5,134 | — | 4,391 | — | 4,391 | 5,134 | — | 4,562 | — | 4,562 |
| BGE | 4,602 | — | 4,015 | — | 4,015 | 4,602 | — | 4,145 | — | 4,145 |
| PHI | 9,153 | — | 4,356 | 3,613 | 7,969 | 8,648 | — | 4,160 | 3,442 | 7,602 |
| Pepco | 4,359 | — | 2,549 | 1,570 | 4,119 | 4,096 | — | 2,311 | 1,600 | 3,911 |
| DPL | 2,254 | — | 668 | 1,274 | 1,942 | 2,080 | — | 694 | 1,134 | 1,828 |
| ACE | 1,909 | — | 929 | 768 | 1,697 | 1,833 | — | 939 | 708 | 1,647 |
| Long-Term Debt to Financing Trusts | ||||||||||
| Exelon | $390 | $— | $— | $392 | $392 | $390 | $— | $— | $390 | $390 |
| ComEd | 205 | — | — | 209 | 209 | 205 | — | — | 208 | 208 |
| PECO | 184 | — | — | 183 | 183 | 184 | — | — | 182 | 182 |
(a)Includes unamortized debt issuance costs, unamortized debt discount and premium, net, purchase accounting fair value adjustments, and finance lease liabilities which are not fair valued. Refer to Note 16 — Debt and Credit Agreements of the 2023 Form 10-K for unamortized debt issuance costs, unamortized debt discount and premium, net, and purchase accounting fair value adjustments and Note 10 — Leases of the 2023 Form 10-K for finance lease liabilities.
Recurring Fair Value Measurements
The following tables present assets and liabilities measured and recorded at fair value in the Registrants' Consolidated Balance Sheets on a recurring basis and their level within the fair value hierarchy at March 31, 2024 and December 31, 2023. Exelon and the Utility Registrants have immaterial andno financial assets or liabilities measured using the NAV practical expedient, respectively:
Exelon
| At March 31, 2024 | At December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |
| Assets | ||||||||
| Cash equivalents(a) | $883 | $— | $— | $883 | $618 | $— | $— | $618 |
| Rabbi trust investments | ||||||||
| Cash equivalents | 68 | — | — | 68 | 67 | — | — | 67 |
| Mutual funds | 57 | — | — | 57 | 53 | — | — | 53 |
| Fixed income | — | 7 | — | 7 | — | 7 | — | 7 |
| Life insurance contracts | — | 65 | 43 | 108 | — | 61 | 43 | 104 |
| Rabbi trust investments subtotal | 125 | 72 | 43 | 240 | 120 | 68 | 43 | 231 |
| Interest rate derivative assets | ||||||||
| Derivatives designated as hedging instruments | — | 2 | — | 2 | — | 11 | — | 11 |
| Economic hedges | — | — | — | — | — | 1 | — | 1 |
| Interest rate derivative assets subtotal | — | 2 | — | 2 | — | 12 | — | 12 |
| Total assets | 1,008 | 74 | 43 | 1,125 | 738 | 80 | 43 | 861 |
| Liabilities | ||||||||
| Commodity derivative liabilities | — | — | (108) | (108) | — | — | (133) | (133) |
| Interest rate derivative liabilities | ||||||||
| Derivatives designated as hedging instruments | — | (1) | — | (1) | — | (24) | — | (24) |
| Economic hedges | — | — | — | — | — | (22) | — | (22) |
| Interest rate derivative liabilities subtotal | — | (1) | — | (1) | — | (46) | — | (46) |
| Deferred compensation obligation | — | (75) | — | (75) | — | (75) | — | (75) |
| Total liabilities | — | (76) | (108) | (184) | — | (121) | (133) | (254) |
| Total net assets (liabilities) | $1,008 | $(2) | $(65) | $941 | $738 | $(41) | $(90) | $607 |
(a)Exelon excludes cash of $271 million and $334 million at March 31, 2024 and December 31, 2023, respectively, and restricted cash of $154 million and $149 million at March 31, 2024 and December 31, 2023, respectively, and includes long-term restricted cash of $99 million and $174 million at March 31, 2024 and December 31, 2023, respectively, which is reported in Other deferred debits and other assets in the Consolidated Balance Sheets.
ComEd, PECO, and BGE
| ComEd | PECO | BGE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At March 31, 2024 | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Assets | ||||||||||||
| Cash equivalents(a) | $398 | $— | $— | $398 | $14 | $— | $— | $14 | $— | $— | $— | $— |
| Rabbi trust investments | ||||||||||||
| Mutual funds | — | — | — | — | 10 | — | — | 10 | 10 | — | — | 10 |
| Life insurance contracts | — | — | — | — | — | 19 | — | 19 | — | — | — | — |
| Rabbi trust investments subtotal | — | — | — | — | 10 | 19 | — | 29 | 10 | — | — | 10 |
| Total assets | 398 | — | — | 398 | 24 | 19 | — | 43 | 10 | — | — | 10 |
| Liabilities | ||||||||||||
| Commodity derivative liabilities(b) | — | — | (108) | (108) | — | — | — | — | — | — | — | — |
| Deferred compensation obligation | — | (9) | — | (9) | — | (9) | — | (9) | — | (4) | — | (4) |
| Total liabilities | — | (9) | (108) | (117) | — | (9) | — | (9) | — | (4) | — | (4) |
| Total net assets (liabilities) | $398 | $(9) | $(108) | $281 | $24 | $10 | $— | $34 | $10 | $(4) | $— | $6 |
| ComEd | PECO | BGE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At December 31, 2023 | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Assets | ||||||||||||
| Cash equivalents(a) | $453 | $— | $— | $453 | $9 | $— | $— | $9 | $— | $— | $— | $— |
| Rabbi trust investments | ||||||||||||
| Mutual funds | — | — | — | — | 9 | — | — | 9 | 9 | — | — | 9 |
| Life insurance contracts | — | — | — | — | — | 18 | — | 18 | — | — | — | — |
| Rabbi trust investments subtotal | — | — | — | — | 9 | 18 | — | 27 | 9 | — | — | 9 |
| Total assets | 453 | — | — | 453 | 18 | 18 | — | 36 | 9 | — | — | 9 |
| Liabilities | ||||||||||||
| Commodity derivative liabilities(b) | — | — | (133) | (133) | — | — | — | — | — | — | — | — |
| Deferred compensation obligation | — | (8) | — | (8) | — | (8) | — | (8) | — | (4) | — | (4) |
| Total liabilities | — | (8) | (133) | (141) | — | (8) | — | (8) | — | (4) | — | (4) |
| Total net assets (liabilities) | $453 | $(8) | $(133) | $312 | $18 | $10 | $— | $28 | $9 | $(4) | $— | $5 |
(a)ComEd excludes cash of $75 million and $86 million at March 31, 2024 and December 31, 2023, respectively, and restricted cash of $154 million and $147 million at March 31, 2024 and December 31, 2023, respectively. Additionally, ComEd includes long-term restricted cash of $99 million and $174 million at March 31, 2024 and December 31, 2023, respectively, which is reported in Other deferred debits and other assets in the Consolidated Balance Sheets. PECO excludes cash of $34 million and $42 million at March 31, 2024 and December 31, 2023, respectively. BGE excludes cash of $27 million and $47 million at March 31, 2024 and December 31, 2023, respectively, and restricted cash ofzero and $1 million at March 31, 2024 and December 31, 2023, respectively.
(b)The Level 3 balance consists of the current and noncurrent liability of $29 million and $79 million, respectively, at March 31, 2024 and $27 million and $106 million, respectively, at December 31, 2023 related to floating-to-fixed energy swap contracts with unaffiliated suppliers.
PHI, Pepco, DPL, and ACE
| At March 31, 2024 | At December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| PHI | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Assets | ||||||||
| Cash equivalents(a) | $438 | $— | $— | $438 | $107 | $— | $— | $107 |
| Rabbi trust investments | ||||||||
| Cash equivalents | 65 | — | — | 65 | 64 | — | — | 64 |
| Mutual funds | 9 | — | — | 9 | 9 | — | — | 9 |
| Fixed income | — | 7 | — | 7 | — | 7 | — | 7 |
| Life insurance contracts | — | 22 | 41 | 63 | — | 21 | 41 | 62 |
| Rabbi trust investments subtotal | 74 | 29 | 41 | 144 | 73 | 28 | 41 | 142 |
| Total assets | 512 | 29 | 41 | 582 | 180 | 28 | 41 | 249 |
| Liabilities | ||||||||
| Deferred compensation obligation | — | (12) | — | (12) | — | (13) | — | (13) |
| Total liabilities | — | (12) | — | (12) | — | (13) | — | (13) |
| Total net assets | $512 | $17 | $41 | $570 | $180 | $15 | $41 | $236 |
| Pepco | DPL | ACE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At March 31, 2024 | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Assets | ||||||||||||
| Cash equivalents(a) | $192 | $— | $— | $192 | $241 | $— | $— | $241 | $— | $— | $— | $— |
| Rabbi trust investments | ||||||||||||
| Cash equivalents | 64 | — | — | 64 | — | — | — | — | — | — | — | — |
| Life insurance contracts | — | 22 | 41 | 63 | — | — | — | — | — | — | — | — |
| Rabbi trust investments subtotal | 64 | 22 | 41 | 127 | — | — | — | — | — | — | — | — |
| Total assets | 256 | 22 | 41 | 319 | 241 | — | — | 241 | — | — | — | — |
| Liabilities | ||||||||||||
| Deferred compensation obligation | — | (1) | — | (1) | — | — | — | — | — | — | — | — |
| Total liabilities | — | (1) | — | (1) | — | — | — | — | — | — | — | — |
| Total net assets | $256 | $21 | $41 | $318 | $241 | $— | $— | $241 | $— | $— | $— | $— |
| Pepco | DPL | ACE | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| At December 31, 2023 | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| Assets | ||||||||||||
| Cash equivalents(a) | $23 | $— | $— | $23 | $1 | $— | $— | $1 | $— | $— | $— | $— |
| Rabbi trust investments | ||||||||||||
| Cash equivalents | 63 | — | — | 63 | — | — | — | — | — | — | — | — |
| Life insurance contracts | — | 21 | 41 | 62 | — | — | — | — | — | — | — | — |
| Rabbi trust investments subtotal | 63 | 21 | 41 | 125 | — | — | — | — | — | — | — | — |
| Total assets | 86 | 21 | 41 | 148 | 1 | — | — | 1 | — | — | — | — |
| Liabilities | ||||||||||||
| Deferred compensation obligation | — | (1) | — | (1) | — | — | — | — | — | — | — | — |
| Total liabilities | — | (1) | — | (1) | — | — | — | — | — | — | — | — |
| Total net assets | $86 | $20 | $41 | $147 | $1 | $— | $— | $1 | $— | $— | $— | $— |
(a)PHI excludes cash of $89 million and $96 million at March 31, 2024 and December 31, 2023, respectively, and restricted cash ofzero and $1 million at March 31, 2024 and December 31, 2023, respectively. Pepco excludes cash of $28 million and $48 million at March 31, 2024 and December 31, 2023, respectively, and restricted cash ofzero and $1 million at March 31, 2024 and December 31, 2023, respectively. DPL excludes cash of $29 million and $15 million at March 31, 2024 and December 31, 2023, respectively. ACE excludes cash of $27 million and $21 million at March 31, 2024 and December 31, 2023, respectively.
Reconciliation of Level 3 Assets and Liabilities
The following tables present the fair value reconciliation of Level 3 assets and liabilities measured at fair value on a recurring basis during the three months ended March 31, 2024 and 2023:
| Exelon | ComEd | PHI and Pepco | |
|---|---|---|---|
| Three Months Ended March 31, 2024 | Total | CommodityDerivatives | Life Insurance Contracts |
| Balance at December 31, 2023 | $(90) | $(133) | $41 |
| Total realized / unrealized gains (losses) | |||
| Included in net income(a) | — | — | — |
| Included in regulatory assets/liabilities | 25 | 25(b) | — |
| Balance at March 31, 2024 | $(65) | $(108)(c) | $41 |
| The amount of total gains included in income attributed to the change in unrealized gains related to assets and liabilities at March 31, 2024 | $— | $— | $— |
| Exelon | ComEd | PHI and Pepco | |
|---|---|---|---|
| Three Months Ended March 31, 2023 | Total | CommodityDerivatives | Life Insurance Contracts |
| Balance at December 31, 2022 | $(44) | $(84) | $40 |
| Total realized / unrealized gains (losses) | |||
| Included in net income(a) | 1 | — | 1 |
| Included in regulatory assets/liabilities | (14) | (14)(b) | — |
| Balance at March 31, 2023 | $(57) | $(98) | $41 |
| The amount of total gains included in income attributed to the change in unrealized gain related to assets and liabilities at March 31, 2023 | $1 | $— | $1 |
(a)Classified in Operating and maintenance expense in the Consolidated Statements of Operations and Comprehensive Income.
(b)Includes $13 million of increases in fair value and an increase for realized gains due to settlements of $12 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the three months ended March 31, 2024. Includes $25 million of decreases in fair value and an increase for realized losses due to settlements of $11 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the three months ended March 31, 2023.
(c)The balance of the current and noncurrent asset was effectively zero as of March 31, 2024. The balance consists of a current and noncurrent liability of $29 million and $79 million, respectively, as of March 31, 2024.
Commodity Derivatives (Exelon and ComEd)
The table below discloses the significant unobservable inputs to the forward curve used to value mark-to-market derivatives.
| Type of trade · Fair Value at March 31, 2024 · Fair Value at December 31, 2023 · ValuationTechnique · UnobservableInput · 2024 Range & Arithmetic Average · 2023 Range & Arithmetic Average | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commodity derivatives | $(108) | $(133) | DiscountedCash Flow | Forward power price(a) | $22.68 | - | $84.62 | $46.94 | $30.27 | - | $73.71 | $43.35 |
(a)An increase to the forward power price would increase the fair value.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.